Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-17-001520
Filing Date
2017-09-20
Accepted
2017-09-20 16:32:45
Documents
1
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 form4-09202017_010935.html 4  
1 form4-09202017_010935.xml 4 4092
  Complete submission text file 0001415889-17-001520.txt   5520
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Smith Mark Alan (Reporting) CIK: 0001677452 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37761 | Film No.: 171094288